MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Tuesday, June 21, 2016

12:30pm-2:00pm
Generation of dopaminergic neurons for studying Parkinson’s disease using patient blood cells

D. Ma, W. Zhou, Y. Chao, Y. Zhao, E.K. Tan (Singapore, Singapore)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Generation of human induced pluripotent stem cells carrying a safety bet for cell-based therapy in Parkinson’s disease

Y. Kimura, Y. Kanemura, T. Shofuda, M. Onodera, M. Oda, M. Nakamori, T. Nakano, H. Mochizuki (Osaka, Japan)

Therapy in movement disorders: Gene and cell-based therapies  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Genetic analysis of CHCHD2 gene in Parkinson’s disease in a Taiwanese population

T.S. Fan, H.I. Lin, C.H. Lin, R.M. Wu (Taipei, Taiwan)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Genetic analysis of eighty-seven multiple system atrophy patients

G. Franco, D. Ronchi, I. Trezzi, L. Borellini, F. Del Sorbo, B. Garavaglia, A.E. Elia, G. Ardolino, G. Mora, S. Bonato, N. Bresolin, G.P. Comi, A. Di Fonzo (Milan, Italy)

Genetics (NON-PD)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Genetic Identification of early-onset parkinsonism among Norwegian patients

E.K. Gustavsson, J. Trinh, M. McKenzie, S. Bortnick, J.O. Aasly, M.J. Farrer (Vancouver, BC, Canada)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Genetic risk factors of dementia and psychosis in Parkinson’s disease

T. Oeda, A. Umemura, Y. Mori, S. Tomita, M. Kohsaka, K. Park, K. Inoue, H. Fujimura, H. Hasegawa, H. Sugiyama, H. Sawada (Kyoto, Japan)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Genetic variation near the SNCA gene associates with Parkinson’s disease motor phenotype and progression

C. Cooper, Y. Berlyand, D. Weintraub, S.X. Xie, A. Espay, J. Quinn, K. Edwards, T. Montine, C. Zabetian, A. Chen-Plotkin (Philadelphia, PA, USA)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Genome-wide bioinformatic analysis of Parkinson’s disease: A focus on neuronal health maintenance

R. Qadri, M.A. Faiq, V. Goyal, A.K. Mukhopadhyay (New Delhi, India)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Glatiramir acetate (Copaxone) causes restoration of the striatal dopamine in a progressive MPTP mouse model of Parkinson’s disease

C.K. Meshul, M.J. Churchill (Portland, OR, USA)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Glucocerebrosidase activity in a cohort of PD patients

I. Trezzi, V. Melzi, G. Franco, L. Borellini, E. Monfrini, A. Bordoni, N. Bresolin, G.P. Comi, A. Di Fonzo (Milan, Italy)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 48
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Nilotinib for treating MSA: A preclinical proof of concept study
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley